Early Rapid Fluid Therapy Is Associated with Increased Rate of Noninvasive Positive-Pressure Ventilation in Hemoconcentrated Patients with Severe Acute Pancreatitis

BACKGROUND/AIMS: Hematocrit is a widely used biomarker to guide early fluid therapy for patients with acute pancreatitis (AP), but there is controversy over whether early rapid fluid therapy (ERFT) should be used in hemoconcentrated patients. This study investigated the association of hematocrit and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lan, Jin, Tao, Wen, Si, Shi, Na, Zhang, Ruwen, Zhu, Ping, Lin, Ziqi, Jiang, Kun, Guo, Jia, Liu, Tingting, Philips, Anthony, Deng, Lihui, Yang, Xiaonan, Singh, Vikesh K., Sutton, Robert, Windsor, John A., Huang, Wei, Xia, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419345/
https://www.ncbi.nlm.nih.gov/pubmed/31912265
http://dx.doi.org/10.1007/s10620-019-05985-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419345/
https://www.ncbi.nlm.nih.gov/pubmed/31912265
http://dx.doi.org/10.1007/s10620-019-05985-w

Ejemplares similares